
Wondfo Biotech
Asia, Guangdong, China, Huangpu'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
Description
Wondfo Biotech specializes in providing healthcare products and services.
Investor Profile
Wondfo Biotech has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 0 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series D rounds (top funding stages).
- Majority of deals are located in China, United States.
- Strong thematic focus on Health Care, Health Diagnostics, Artificial Intelligence (AI).
Stage Focus
- Series B (67%)
- Series D (33%)
Country Focus
- China (67%)
- United States (33%)
Industry Focus
- Health Care
- Health Diagnostics
- Artificial Intelligence (Ai)
- Machine Learning
- Robotics
- Medical Device
- Mobile
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.